Convalesce Inc.

Convalesce Inc. is a biotechnology startup founded in 2018 in the United States. The company's slogan, "Controlling Stem Cell Fate Post-transplantation", succinctly captures its mission. Convalesce focuses on enabling stem cell-based therapy for neurodegenerative conditions, particularly Parkinson's, by harnessing state-of-the-art biomaterials. In April 2020, the company received a Convertible Note investment from SOSV and indiebio, indicating strong support and interest from prominent investors in the biotech and healthcare sectors. This infusion of capital will likely further the company's research and development efforts, as well as advance its clinical trials. Convalesce's innovative approach to addressing neurodegenerative diseases holds significant promise and positions it as a compelling investment opportunity within the biotechnology landscape.